Network and Systems Medicine Academy

Every Disease Is a Network. We Train People to See It.

The Network & Systems Medicine Academy is built on a simple belief: tomorrow's breakthroughs will come from understanding diseases as interconnected biological networks—not isolated symptoms or single genes. Our mission is to bridge the gap between learning science and doing meaningful research.

Whether you are a high school student, an undergraduate, a healthcare professional expanding your expertise, or a researcher seeking new skills, the Academy provides a structured pathway from foundational knowledge to advanced, mentor-guided research. At NSM Academy, you don't just learn about network and systems medicine—you become part of the next generation advancing it.

Explore Research Areas

Find Your Track

WHY NETWORK AND SYSTEMS MEDICINE

The Body Doesn't Fail One Piece at a Time

Network and systems medicine studies disease as an interconnected system — genes, proteins, cells, organs — rather than damage to a single isolated part. A disease is rarely one broken gene; it's a disruption spreading across a cluster of connected components, what researchers call a disease module. This mechanism-based approach maps that disrupted module to find better diagnostics, drug targets, and treatments.

A disrupted disease module highlighted within the wider biological network

A cancer mutation rarely acts alone — it reshapes an entire signaling network, which is why oncologists now hunt for network hubs, not just the first mutation found.

A virus hijacks specific host proteins at the center of our cellular machinery, which is why mapping those host-pathogen networks speeds drug repurposing during outbreaks.

Autoimmune diseases that look unrelated — rheumatoid arthritis, lupus, psoriasis — often share the same inflammatory networks, which is exactly why a drug for one so often treats another.

The old model — one gene, one disease, one drug — is running out of road: two patients with an identical diagnosis can carry entirely different disease modules, so one size does not fit all.

The result is a new kind of physician and biomedical scientist: one as fluent in systems principles as in data.

Grounded in the Founding Research

Albert-László Barabási and Joseph Loscalzo helped establish network medicine as a field with their 2011 review in Nature Reviews Genetics, showing that disease reflects disruption across networks of molecular interactions — not one failed gene. That paper introduced the disease module; their 2017 textbook, Network Medicine: Complex Systems in Human Disease and Therapeutics (Harvard University Press), remains foundational.

Harald Schmidt, professor of pharmacology at Maastricht University, pushes the field toward the clinic: define disease by its causal mechanism, not its symptoms. His 2022 review in Trends in Pharmacological Sciences shows how network pharmacology — combining existing drugs against the several targets driving a disease — can replace slow, expensive drug discovery.